The DOI matches its Crossref record; 58 of the 60 references it cites were found in a registry or an index.
The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2
Open accessAbstract
Proximity-dependent biotin labeling (BioID) may identify new targets for cancers driven by difficult-to-drug oncogenes such as Ras. Therefore, BioID was used with wild-type (WT) and oncogenic mutant (MT) H-, K-, and N-Ras, identifying known interactors, including Raf and PI3K, as well as a common set of 130 novel proteins proximal to all Ras isoforms. A CRISPR screen of these proteins for Ras dependence identified mTOR, which was also found proximal to MT Ras in human tumors. Oncogenic Ras directly bound two mTOR complex 2 (mTORC2) components, mTOR and MAPKAP1, to promote mTORC2 kinase activity at the plasma membrane. mTORC2 enabled the Ras pro-proliferative cell cycle transcriptional program, and perturbing the Ras-mTORC2 interaction impaired Ras-dependent neoplasia in vivo. Combining proximity-dependent proteomics with CRISPR screening identified a new set of functional Ras-associated proteins, defined mTORC2 as a new direct Ras effector, and offers a strategy for finding new proteins that cooperate with dominant oncogenes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional biochemical, structural, and signaling distinctions have been identified between different mutant alleles, including between those at the same amino acid position4,8,13–20.”
From The origins and genetic interactions of KRAS mutations are allele- and tissue-specific (2021) · cites this paper as [16]
In the citing paper
“four interact with or signal through KRAS16,38 or are known oncogenes or tumor suppressors39: TP53, RNF43, MAP2K4, and RBM10”
From The origins and genetic interactions of KRAS mutations are allele- and tissue-specific (2021) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Benavides-Serrato, A., Lee, J., Holmes, B., Landon, K. A., Bashir, T., Jung, M. E., Lichtenstein, A. K., & Gera, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176599 · Cited by 82
RetractedFiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
STRING v10: protein–protein interaction networks, integrated over the tree of life
Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K. P., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1003 · Cited by 10,436
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Chen, E. Y., Tan, C. M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G. V., Clark, N. R., & Ma’ayan, A. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-128 · Cited by 7,814
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
In-gel digestion for mass spectrometric characterization of proteins and proteomes
Shevchenko, A., Tomas, H., Havli, J., Olsen, J. V., & Mann, M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.468 · Cited by 4,947
Flagged first, then by citations
2 of the 60 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–154 of 154
Structural insights into the complex of oncogenic KRas4B G12V and Rgl2, a RalA/B activator
Tariq, M., Ikeya, T., Togashi, N., Fairall, L., Kamei, S., Mayooramurugan, S., Abbott, L. R., Hasan, A., Bueno-Alejo, C. J., Sukegawa, S., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202302080 · Cited by 6
gRASping Depolarization: Contribution of RAS GTPases to Mitotic Polarity Clusters Resolution
Quadri, R., Sertic, S., & Muzi-Falconi, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.589993 · Cited by 6
Gaudreault, V., Marchand, B., Larcher, R., Nassari, S., Bourassa, F., Moreau, M., Jean, D., Boisvert, F., Brunet, M. A., & Jean, S. (2025) · Communications Biology · doi:10.1038/s42003-025-09121-5 · Cited by 7
Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer development
Koo, H., Park, K., Sohn, H., Kang, M.-H., Kim, D. J., Park, Z.-Y., Park, S., Min, S.-H., Park, S.-H., You, Y.-M., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-54476-8 · Cited by 6
Ang II Controls the Expression of Mapkap1 by miR-375 and Affects the Function of Islet β Cells
Lin, X., Cheng, L., Wan, Y., Yan, Y., Zhang, Z., Li, X., Wu, J., Wang, X., & Xu, M. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230206121715 · Cited by 5
Ancient complexes of iron and sulfur modulate oncogenes and oncometabolism
Nghi, H. T., Shahmohammadi, S., & Ebrahimi, K. H. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102338 · Cited by 5
Kyriakopoulos, G. C., Katopodi, V., Skeparnias, I., Kaliatsi, E. G., Grafanaki, K., & Stathopoulos, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042222 · Cited by 5
Neuron navigators: A novel frontier with physiological and pathological implications
Sandeep, P., Sharma, P., Luhach, K., Dhiman, N., Kharkwal, H., & Sharma, B. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103905 · Cited by 5
Wang, S., Zhang, C., Li, M., Zhao, C., & Zheng, Y. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c00651 · Cited by 6
Oncogenic KRAS engages an RSK1/NF1 complex in pancreatic cancerPreprint
Cheng, D. K., Oni, T. E., Park, Y., Thalappillil, J. S., Ting, H.-C., Alagesan, B., Prasad, N. V., Rivera, K. D., Pappin, D., Aelst, L. V., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.14.295394 · Cited by 3
Damianou, A., Liang, Z., Lassen, F. H., Vere, G., Hester, S., Charles, P. D., Pinto-Fernández, A., Santos-Delgado, A., Fischer, R., & Kessler, B. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.23.469679 · Cited by 3
Ivanišević, T., Magits, W., Ma, Y., Zhao, P., Boxel, E. V., Lechat, B., Stites, E. C., Velde, G. V., Sewduth, R. N., & Sablina, A. A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.27.582346 · Cited by 3
Impact of Rapamycin on Longevity: Updated Insights
Sanati, M., Afshari, A. R., Aminyavari, S., Banach, M., & Sahebkar, A. (2024) · Archives of Medical Science · doi:10.5114/aoms/191565 · Cited by 3
Yu, P.-C., Kao, Y.-C., Chang, H., Huang, C.-H., Hsu, W., Huang, H., & Juan, H. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00191 · Cited by 4
Burge, R. A., Bialousow, L., McFall, T. B., Bamonte, L., Johnson, G., Smith, M., Vaena, S. G., Comte‐Walters, S., Ball, L. E., Berto, S., et al. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0281 · Cited by 2
Unlocking TRPM7 interactions: A database-driven quest
Jonckheere, N., Rodat‐Despoix, L., Duthille, I., Girault, A., Hague, F., & Gautier, M. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.11.030 · Cited by 2
Sensitivity of Oncogenic KRAS-Expressing Cells to CDK9 Inhibition
Lai, L., Brel, V., Sharma, K., Frappier, J., Le-Henanf, N., Vivet, B., Muzet, N., Schell, E., Morales, R., Rooney, E. K., et al. (2021) · SLAS DISCOVERY · doi:10.1177/24725552211008853 · Cited by 2
CD146 Regulates Growth Factor-Induced mTORC2 Activity Independent of PI3K and mTORC1 PathwaysPreprint
Xu, W., Hua, H., Chiu, Y.-H., Li, G., Zhi, H., Yu, Z., Ren, F., Luo, Y., & Cui, W. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3388356 · Cited by 2
mTORC2 coordinates the leading and trailing edge cytoskeletal programs during neutrophil migrationPreprint
Saha, S., Town, J. P., & Weiner, O. D. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.25.484773 · Cited by 2
Liprin‐α1 contributes to oncogenic MAPK signaling by counteracting ERK activity
Pehkonen, H., Filippou, A., Väänänen, J., Lindfors, I., Vänttinen, M., Ianevski, P., Mäkelä, A. M., Munne, P., Klefström, J. T., Toppila-Salmi, S. K., et al. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13593 · Cited by 1
Molecular determinants of Ras-mTORC2 signaling
Smith, S. F., Islam, A. F. M. T., Alimukhamedov, S., Weiss, E. T., & Charest, P. G. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107423 · Cited by 1
Phosphatase PTPN22 functions as an adaptor in the mTORC2 complex
Gupta, K., Kommineni, N., Bogadi, T., Alamuru-Yellapragada, N. P., & Maddika, S. (2025) · EMBO Reports · doi:10.1038/s44319-025-00576-5 · Cited by 1
Pavic, K., Hood, F. E., Duval, C. J., Manoharan, G. B., Laurini, C., Siddiqui, F. A., Mo, S., Prior, I. A., & Abankwa, D. (2025) · iScience · doi:10.1016/j.isci.2025.113974 · Cited by 1
Intrinsic resistance to RAS inhibitors is driven by dysregulation of KRAS degradation
Ivanišević, T., Ma, Y., Boxel, E. V., Magits, W., Lechat, B., Koçberber, Z., Willnow, P., Fendt, S., Velde, G. V., Sewduth, R. N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67109-5 · Cited by 2
A ternary association of KRas, EphA2, and integrins controls PDAC cell behavior
Fatima, M., Haider, N., Cain, S. A., Acharya, B. R., Chastney, M. R., Zha, J., Jones, M., Warwood, S., Knight, D., O'Reilly, D. A., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113421 · Cited by 1
Motif-guided identification of KRAS-interacting proteins
Wu, S., Gao, X., Wu, D., Liu, L., Yao, H., Meng, X., Zhang, X., & Bai, F. (2024) · BMC Biology · doi:10.1186/s12915-024-02067-w · Cited by 1
Jenkins, R. E. (2016)
Faculty Opinions recommendation of mTOR at the nexus of nutrition, growth, ageing and disease.
Ferguson, S. M. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737205281.793574661
Chantaravisoot, N., Wongkongkathep, P., Kalpongnukul, N., Pacharakullanon, N., Kaewsapsak, P., Ariyachet, C., Loo, J. A., Tamanoi, F., & Pisitkun, T. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.12.511677
Endosomal GLUT3 is essential for alternative macrophage signaling, polarization, and functionPreprint
Yu, D.-M., Zhao, J., Lee, E. E., Rose, E. K., Mahapatra, R., Choe, J., Abel, E. D., & Wang, R. C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.09.515804
Vu, N., Kim, M., Stephenson, D., MacKnight, H. P., & Chalfant, C. E. (2023) · doi:10.1158/1541-7786.c.6545652
Mitochondrial Raf1 Regulates Glutamine CatabolismPreprint
Shanderson, R. L., Ferguson, I., Siprashvili, Z., Ducoli, L., Li, A. M., Miao, W., Srinivasan, S., Velasco, M. G. M., Li, Y., Ye, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.08.581297
Self-citationA Proximity MAP of RAB GTPasesPreprint
St-Laurent, V. G., Marchand, B., Larcher, R., Nassari, S., Bourassa, F., Moreau, M., Jean, D., Boisvert, F., Brunet, M. A., & Jean, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.05.621850
Miyan, J., Kumar, N., Moinuddin, Malik, S. A., Akif, U. M., Hameed, R., Riyazuddin, M., Dubey, P., Lal, J., Kumar, A., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03516-8 · Cited by 1
A dominant SRCAP truncating mutation promotes squamous cell carcinoma progression
Droll, S. H., Dewar, E. I. O., Xue, C., Levine, M. C., Zhang, B. J., & Bao, X. (2025) · Oncogenesis · doi:10.1038/s41389-025-00576-z
Yang, Y., Cho, C. Y., Brock, A., Quackenbush, D., Chen, K., Lo, F., Benes, C. H., & Haling, J. R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.14.688534
Thakur, R., Xu, M., Thornock, A. M., Yon, J., Anyaso-Samuel, S., Lauss, M., Rehling, T., Bui, L. T., Sowards, H., Duncan, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.03.691936
A Drosophila eye modifier screen identifies TBC1D25 as a modulator of RAB21 phenotypesPreprint
Normandin, C., Dubois, S., Olmo, T. D., & Jean, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.30.702430
Rôle de la protéine RICTOR dans le développement des mélanomes
Jebali, A. (2020) · theses.fr (ABES) · doi:10.70675/468ac338zaceaz4caaza391zda7d8da0cb2a
Caractérisation de nouvelles dépendances oncogéniques dans les hémopathies myéloïdes
Roux, B. (2022) · theses.fr (ABES) · doi:10.70675/d76b6764z8851z423dza26fz9f68e953227e
The Emerging Role of mTOR in Shaping the Cancer Cell Secretome and Plasticity
Cooper, T. T., Topisirović, I., & Postovit, L.-M. M. (2026) · Molecular and Cellular Biology · doi:10.1080/10985549.2026.2699146
Jo, C. H., Strakhova, R., Goudreault, M., Astrain, G. B., & Smith, M. J. (2026) · Biochemical Journal · doi:10.1042/bcj20260336
Liao, R., Ma, C., Chen, X., Bai, L., Cao, Q., Zhang, Y., & Dong, C. (2026) · 癌症：英文版 · doi:10.34133/cancomm.0047
Jung, N., Lopez-Pajares, V., Donohue, L. K. H., Guo, M. G., Srinivasan, S., Siprashvili, Z., & Khavari, P. A. (2026) · Science Advances · doi:10.1126/sciadv.adz9441
Self-citationmTOR-Mediated Neuron–Cancer Interactions
Nyarkoh, J. K., Wolan, M. J., & Feliciano, D. M. (2026) · Kinases and Phosphatases · doi:10.3390/kinasesphosphatases4030024
Mitochondrial Raf1 regulates glutamine catabolism
Shanderson, R. L., Ferguson, I., Ducoli, L., Miao, W., Srinivasan, S., Siprashvili, Z., Li, A. M., Velasco, M. G. M., Li, Y., Hoang, C. N., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117975
Self-citationThakur, R., Xu, M., Thornock, A., Yon, J., Anyaso-Samuel, S., Lauss, M., Rehling, T., Bui, L. T., Sowards, H., Duncan, G., et al. (2026) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2026.08.014 · Cited by 1
Yang, Y., Liu, T., Cho, C. Y., Liu, X., Brock, A., Quackenbush, D., Chen, K., Lo, F., Benes, C. H., & Haling, J. R. (2026) · Oncogene · doi:10.1038/s41388-026-04017-y
Metadata
- Authors
- Kovalski, J. R., Bhaduri, A., Zehnder, A. M., Neela, P. H., Che, Y., Wozniak, G. G., & Khavari, P. A.
- Affiliations
- Stanford Medicine (US)
- University of California, San Francisco (US)
- Stanford University (US)
- VA Palo Alto Health Care System (US)
- Corresponding author
- Khavari, Paul A.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 73
- Issue
- 4
- Pages
- 830-844.e12
- ISSN
- 1097-2765 (ISSN-L)
- PMC
- PMC6386588
- OpenAlex
- W2909177041
- Cited by
- 154
- References
- 60
- Citations by year
- 2026: 10 · 2025: 21 · 2024: 16 · 2023: 25 · 2022: 23 · 2021: 27 · 2020: 22 · 2019: 9
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Veterans Affairs
- NIH (AR43799, CA142635)
- National Center Research Resources (P30 CA124435, S10RR027425)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Biotin and Related Studies
- Keywords
- oncogenic Ras, mTORC2, mTOR, Raf, phosphatidylinositol 3-kinase, CRISPR screen, Ras isoforms
- MeSH terms
- Mechanistic Target of Rapamycin Complex 2, Animals, Binding Sites, Cell Transformation, Neoplastic, Female, Humans, Mice, Hairless, Mice, Transgenic, Mutation, Neoplasms, Protein Binding, Gene Expression Regulation, Neoplastic, Mice, SCID, ras Proteins, Caco-2 Cells, Proteome, Proteomics, Tumor Burden, Cell Proliferation, Protein Interaction Domains and Motifs, HEK293 Cells, Cell Cycle Checkpoints, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
